Crossmark

Effects of GLP-1 receptor agonists and SGLT-2 inhibitors on cardiac structure and function: a narrative review of clinical evidence

Published Online: 2021-09-28

Published Print: 2021-12

Authors

Natali, Andrea

Nesti, Lorenzo http://orcid.org/0000-0002-0560-6496
Tricò, Domenico

Ferrannini, Ele
License Information

Text and Data Mining valid from 2021-09-28

Version of Record valid from 2021-09-28
More Information

Article History

Received: 19 July 2021

Accepted: 17 September 2021

First Online: 28 September 2021

Declarations

:

: Not applicable.

: All the authors gave their consent to publication.

: Natali A. has received a grant for an investigator initiated clinical study from Boheringer-Ingelheim and onoraria as speakers from Eli-Lilly, Servier, Astra Zeneca. Ferranini E. has served on the Advisory Board of Boehringer Ingelheim/Lilly&Co., Servier, Lexicon, and Oramed, has received research grants from Boehringer Ingelheim/Lilly&Co and Janssen, and speaker fees from Boehringer Ingelheim/Lilly&Co. and MSD. LN, DT, and AM have no conflict of interest to disclose.

Document is current